Iridium Communications heads into its September 24 earnings report with options traders more defensive than at almost any point in the past year.
The clearest pre-earnings signal is the put/call ratio. It has jumped to 0.61, nearly 2.8 standard deviations above its 20-day average of 0.50 — placing it right at the 52-week high of 0.62. That is a meaningful shift. Through most of August, the PCR was running below 0.25, reflecting a strongly call-heavy book. The rotation into puts over the past month points to genuine hedging demand ahead of the release. The stock itself has drifted slightly lower on the month, down about 0.7% to $48.65, though it has recovered roughly 3% on the week, suggesting the pullback has found some buyers.
Short interest, by contrast, tells a far less anxious story. Bears have covered aggressively — short interest has fallen more than 26% over the past month to just 2.6% of the float, a low and unexciting reading. The borrow market confirms this: availability is vast, with nearly 18 shares available to borrow for every one currently lent out, and cost to borrow has eased nearly 20% on the week to 0.42%. There is no meaningful squeeze pressure here, and the ORTEX short score of 33.6 is well into the lower half of the range. Options traders are buying protection; short sellers are stepping back.
The analyst community is divided, and the stock's recent run has complicated the debate. The consensus is a hold, with a mean price target of $42 — materially below the current price of $48.65. That gap deserves attention: even the more constructive voices on the Street have yet to fully chase the stock's gains. Morgan Stanley raised its target to $54 in late June while holding an Equal-Weight rating, and Oppenheimer moved its Outperform target to $60 around the same time. But Barclays sits at $36 and BWS Financial has maintained a $16 Sell. Bulls point to Iridium's diversified revenue base, government contracts, and IoT optionality via the Satelles acquisition. Bears flag stagnant core subscriber growth, competitive pressure from LEO entrants, and a forward earnings multiple above 31x that leaves little room for disappointment. The 90-day EPS momentum factor ranks in the 92nd percentile, supporting the bull case on earnings trajectory — but the 30-day reading has collapsed to the 9th percentile, a sharp near-term reversal worth watching.
There is also an activist angle. Baralonco Limited holds a 9.44% stake under a Schedule 13D/A filing, last updated August 4. An activist on the register at that level is one of the more significant structural facts about the stock. Separately, AQR Capital added more than four million shares in the most recent filing period, crossing 6.5% of the float — a notable institutional commitment. On the insider side, the EVP of Sales made two open-market sales in September totalling around $360,000, both outside a 10b5-1 plan. Those were modest in size but are worth noting given the valuation debate. Past earnings prints have produced muted one-day reactions — the last two moved less than 2% on the day — though the five-day windows have been more volatile, with a 17.9% gain after the May print and a 6.1% loss following July's report.
Tomorrow's print is ultimately a test of whether Iridium's subscriber and revenue trajectory can justify a stock that has re-rated well above where most of the analyst community is currently willing to plant a flag.
See the live data behind this article on ORTEX.
Open IRDM on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
